Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $289.62 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $130.46 | 1 | $0 (2018) |
| Biogen, Inc. | $46.70 | 2 | $0 (2024) |
| Lundbeck LLC | $41.49 | 2 | $0 (2021) |
| Amgen Inc. | $32.00 | 2 | $0 (2021) |
| Itamar Medical Inc | $19.54 | 1 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $19.43 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.39 | 1 | Biogen, Inc. ($29.39) |
| 2023 | $19.54 | 1 | Itamar Medical Inc ($19.54) |
| 2021 | $72.85 | 4 | Lundbeck LLC ($41.49) |
| 2020 | $17.95 | 1 | Amgen Inc. ($17.95) |
| 2018 | $149.89 | 2 | Allergan Inc. ($130.46) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/11/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: Neurology | ||||||
| 08/22/2023 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $19.54 | General |
| Category: Sleep Apnea testing | ||||||
| 08/21/2021 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.73 | General |
| Category: NEUROLOGY | ||||||
| 07/14/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: NEUROLOGY | ||||||
| 02/02/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Neuroscience | ||||||
| 01/30/2021 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.76 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2020 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Neuroscience | ||||||
| 05/17/2018 | Allergan Inc. | BOTOX - NEUROLOGY (Drug) | Food and Beverage | In-kind items and services | $130.46 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2018 | Avanir Pharmaceuticals, Inc. | ONZETRA Xsail (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Migraine | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 224 | 299 | $117,527 | $21,522 |
| 2022 | 9 | 294 | 416 | $141,896 | $30,394 |
| 2021 | 11 | 425 | 578 | $167,981 | $50,525 |
| 2020 | 3 | 61 | 64 | $10,288 | $4,610 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 74 | 117 | $21,889 | $11,774 | 53.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 20 | 20 | $38,340 | $1,930 | 5.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $3,172 | $1,751 | 55.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 24 | $2,808 | $1,600 | 57.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 28 | 60 | $5,220 | $1,400 | 26.8% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 14 | 14 | $23,772 | $1,208 | 5.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 22 | $1,584 | $1,016 | 64.1% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 29 | 29 | $20,742 | $842.84 | 4.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 96 | 161 | $28,630 | $16,610 | 58.0% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 23 | 23 | $30,130 | $2,976 | 9.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 24 | 24 | $30,672 | $2,394 | 7.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 39 | $4,290 | $2,388 | 55.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 41 | 86 | $6,794 | $2,050 | 30.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 18 | 18 | $20,376 | $1,628 | 8.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 21 | $1,500 | $890.72 | 59.4% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 12 | 12 | $13,488 | $858.69 | 6.4% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2022 | 28 | 32 | $6,016 | $598.00 | 9.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 144 | 243 | $53,984 | $28,644 | 53.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 70 | $11,315 | $5,750 | 50.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 28 | 28 | $8,680 | $3,590 | 41.4% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Facility | 2021 | 25 | 26 | $30,212 | $2,625 | 8.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 47 | $4,285 | $2,438 | 56.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 47 | 84 | $6,300 | $2,087 | 33.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $3,935 | $1,535 | 39.0% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2021 | 12 | 12 | $12,348 | $1,167 | 9.5% |
About Dr. Michelle Devine, MD
Dr. Michelle Devine, MD is a Neurology healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2014. The National Provider Identifier (NPI) number assigned to this provider is 1891113833.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Devine, MD has received a total of $289.62 in payments from pharmaceutical and medical device companies, with $29.39 received in 2024. These payments were reported across 9 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($289.62).
As a Medicare-enrolled provider, Devine has provided services to 1,004 Medicare beneficiaries, totaling 1,357 services with total Medicare billing of $107,051. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Sleep Medicine
- Location Rochester, MN
- Active Since 04/06/2014
- Last Updated 01/18/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1891113833
Products in Payments
- BOTOX - NEUROLOGY (Drug) $130.46
- VYEPTI (Biological) $41.49
- Aimovig (Biological) $32.00
- TYSABRI (Biological) $29.39
- WatchPATONE (Device) $19.54
- ONZETRA Xsail (Drug) $19.43
- ADUHELM (Biological) $17.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Rochester
Karl Kieburtz, Md, MD
Neurology — Payments: $405,017
Dr. Michael Dunn, M.d, M.D
Neurology — Payments: $325,946
Alejandro Rabinstein, M.d, M.D
Neurology — Payments: $283,073
Dr. Kelly Andrzejewski, D.o., Ph.d, D.O., PH.D
Neurology — Payments: $217,715
John Markman, Md, MD
Neurology — Payments: $206,309
Sean Pittock, M.d, M.D
Neurology — Payments: $196,243